We introduce a major shift from the current paradigm by showing novel cell-intrinsic PD-L1 signaling that promotes TIC generation, virulence and treatment responses, greatly augmenting understanding of PD-L1 signals in cancer pathogenesis and treatment responses. The gene discussed is CD274; the disease is cancer.